Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Ligand Pharmaceuticals Inc (NASDAQ:LGND)

103.47
BATS BZX Real-Time Price
As of 11:33am ET
 +2.21 / +2.18%
Today’s Change
82.06
Today|||52-Week Range
139.79
+1.83%
Year-to-Date

Today’s Trading

Previous close101.26
Today’s open102.11
Day’s range102.11 - 103.83
Volume2,977
Average volume (3 months)360,346
Market cap$2.1B
Dividend yield--
Data as of 11:33am ET, 01/20/2017

Growth & Valuation

Earnings growth (last year)+1,833.30%
Earnings growth (this year)+0.89%
Earnings growth (next 5 years)+40.00%
Revenue growth (last year)+11.43%
P/E ratio369.0
Price/Sales32.00
Price/Book8.51

Competitors

 Today’s
change
Today’s
% change
IRWDIronwood Pharmaceuti...+0.04+0.27%
SAGESAGE Therapeutics In...+0.24+0.45%
ARRYArray Biopharma Inc-0.02-0.18%
SRPTSarepta Therapeutics...-0.78-2.28%
Data as of 11:33am ET, 01/20/2017

Financials

Next reporting dateFebruary 15, 2017
EPS forecast (this quarter)$1.31
Annual revenue (last year)$71.9M
Annual profit (last year)$229.8M
Net profit margin319.58%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
John L. Higgins
President &
Chief Operating Officer
Matthew W. Foehr
Corporate headquarters
San Diego, California

Forecasts


Search for Jobs